Eli Lilly : LLY

All Eli Lilly Articles

618 Articles

Lee Jackson | Sep 12, 2016 at 8:20 AM EDT

4 Safe Large Cap Dividend Stocks to Buy as Market Risk Increases

Investors never take kindly to a 2.45% sell-off, like the one seen in the S&P 500, and they may be…

Jon C. Ogg | Aug 15, 2016 at 1:05 PM EDT

Credit Suisse Issues Top Pharma Picks in Bull/Bear Upside Analysis

Credit Suisse has run bullish and bearish scenarios for what the firm feels is a reasonable upside and downside for…

Lee Jackson | Aug 5, 2016 at 10:20 AM EDT

Jefferies Keeps Red-Hot Dividend Pharmaceutical Stock as Top Sector Pick

A new Jefferies research report features the firm's top pharmaceutical stock picks in order of preference, and AbbVie stays in…

Chris Lange | Jul 26, 2016 at 10:10 AM EDT

Why Eli Lilly Earnings Are So Dynamic

As one of the largest pharmaceutical companies on the street, Eli Lilly helps to set the tempo for the industry.…

Lee Jackson | Jul 26, 2016 at 8:35 AM EDT

Top Analyst Thinks Big Pharmaceutical Stocks Will Outperform the Rest of 2016

SunTrust Robinson Humphrey feels that the major pharmaceutical companies will outperform the rest of the year, and they cite new…

Lee Jackson | Jul 16, 2016 at 9:15 AM EDT

Pharmaceutical Stocks May Be the Best Total Return Play: 3 to Buy Now

With yields plunging and the market getting very pricey, some top pharmaceutical stocks are starting to look like a great…

Douglas A. McIntyre | Jul 9, 2016 at 9:25 AM EDT

Viagra Price Drops 50% as Drug Faces Competition

Viagra, the wildly successful erectile dysfunction pill, faces challenges from a generic version that will launch next year.

Chris Lange | Jun 29, 2016 at 11:47 AM EDT

Eli Lilly Rises on Positive FDA Committee Vote

Eli Lilly and Co. (NYSE: LLY) is watching its shares make a decent gain on Wednesday following a U.S. Food…

Lee Jackson | Jun 9, 2016 at 10:40 AM EDT

4 Merrill Lynch US 1 Portfolio Stocks With Big Total Return Potential

With the market pushing through to all-time highs, we are looking for solid total return ideas for investors. Total return…

Chris Lange | Jun 6, 2016 at 1:40 PM EDT

How Credit Suisse Views Major Pharma After ASCO

The ASCO annual meeting is absolutely making waves in the pharmaceutical industry. As a result, analysts are giving their two…

Chris Lange | Jun 2, 2016 at 10:50 AM EDT

Merrill Lynch Picks ASCO Winners

Merrill Lynch is one of the major firms that will be in attendance at the American Society of Clinical Oncology…

Chris Lange | May 29, 2016 at 10:15 AM EDT

Key Movers to Look for Ahead of ASCO

The American Society of Clinical Oncology (ASCO) is gearing up for its annual meeting. At this meeting, cancer drug developers…

Lee Jackson | May 27, 2016 at 10:50 AM EDT

4 Dividend-Paying Stocks to Help Ride Out the Coming Volatile Summer

Volumes tend to dry up in the summer as traders and investors go on vacation, making it all that much…

Lee Jackson | May 25, 2016 at 10:05 AM EDT

4 UBS Most Preferred Pharmaceutical Stocks That Pay Big Dividends

Despite the ongoing political candidate chirping, all of these quality big pharmaceutical stocks have been around, and they will continue…

Chris Lange | May 19, 2016 at 10:20 AM EDT

8 Stocks on the Move After ASCO Cancer Abstracts

ASCO has just released the abstracts for its exhibitors ahead of the conference. For investors and analysts, sometimes winners or…

1 … 25 26 27 28 29 … 42

Eli Lilly : LLY

All Eli Lilly Articles

4 Safe Large Cap Dividend Stocks to Buy as Market Risk Increases

Credit Suisse Issues Top Pharma Picks in Bull/Bear Upside Analysis

Jefferies Keeps Red-Hot Dividend Pharmaceutical Stock as Top Sector Pick

Why Eli Lilly Earnings Are So Dynamic

Top Analyst Thinks Big Pharmaceutical Stocks Will Outperform the Rest of 2016

Pharmaceutical Stocks May Be the Best Total Return Play: 3 to Buy Now

Viagra Price Drops 50% as Drug Faces Competition

Eli Lilly Rises on Positive FDA Committee Vote

4 Merrill Lynch US 1 Portfolio Stocks With Big Total Return Potential

How Credit Suisse Views Major Pharma After ASCO

Merrill Lynch Picks ASCO Winners

Key Movers to Look for Ahead of ASCO

4 Dividend-Paying Stocks to Help Ride Out the Coming Volatile Summer

4 UBS Most Preferred Pharmaceutical Stocks That Pay Big Dividends

8 Stocks on the Move After ASCO Cancer Abstracts

‘Convert $100,000 a Year to Get Them to the Top of the 22%’: The Roth Plan for a Couple With $2.3M in 401(k)s

UFO ETF Faces a Critical Test: Can Pre-Profit Space Stocks Deliver on $1.85B Backlog

Warren Buffett’s Parting Gift to Investors Is Crushing the Market 6 Months Later

'Convert $100,000 a Year to Get Them to the Top of the 22%': The Roth Plan for a Couple With $2.3M in 401(k)s

College-Educated Families Earned $242,200 While Others Made $42,200, Here's Why the Gap Widened

‘Convert $100,000 a Year to Get Them to the Top of the 22%’: The Roth Plan for a Couple With $2.3M in 401(k)s

UFO ETF Faces a Critical Test: Can Pre-Profit Space Stocks Deliver on $1.85B Backlog

Eli Lilly : LLY

All Eli Lilly Articles

4 Safe Large Cap Dividend Stocks to Buy as Market Risk Increases

Credit Suisse Issues Top Pharma Picks in Bull/Bear Upside Analysis

Jefferies Keeps Red-Hot Dividend Pharmaceutical Stock as Top Sector Pick

Why Eli Lilly Earnings Are So Dynamic

Top Analyst Thinks Big Pharmaceutical Stocks Will Outperform the Rest of 2016

Pharmaceutical Stocks May Be the Best Total Return Play: 3 to Buy Now

Viagra Price Drops 50% as Drug Faces Competition

Eli Lilly Rises on Positive FDA Committee Vote

4 Merrill Lynch US 1 Portfolio Stocks With Big Total Return Potential

How Credit Suisse Views Major Pharma After ASCO

Merrill Lynch Picks ASCO Winners

Key Movers to Look for Ahead of ASCO

4 Dividend-Paying Stocks to Help Ride Out the Coming Volatile Summer

4 UBS Most Preferred Pharmaceutical Stocks That Pay Big Dividends

8 Stocks on the Move After ASCO Cancer Abstracts

‘Convert $100,000 a Year to Get Them to the Top of the 22%’: The Roth Plan for a Couple With $2.3M in 401(k)s

UFO ETF Faces a Critical Test: Can Pre-Profit Space Stocks Deliver on $1.85B Backlog

Warren Buffett’s Parting Gift to Investors Is Crushing the Market 6 Months Later

Featured Reads

'Convert $100,000 a Year to Get Them to the Top of the 22%': The Roth Plan for a Couple With $2.3M in 401(k)s

College-Educated Families Earned $242,200 While Others Made $42,200, Here's Why the Gap Widened